Cwm LLC grew its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 19.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 5,874 shares of the semiconductor company’s stock after acquiring an additional 941 shares during the quarter. Cwm LLC’s holdings in Synopsys were worth $3,012,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in SNPS. Nuveen LLC acquired a new stake in shares of Synopsys during the first quarter worth about $341,480,000. Pictet Asset Management Holding SA boosted its stake in shares of Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after buying an additional 673,837 shares during the period. Generation Investment Management LLP acquired a new stake in shares of Synopsys during the first quarter worth about $240,491,000. Vanguard Group Inc. boosted its stake in shares of Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after buying an additional 346,994 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in shares of Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after buying an additional 313,218 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Trading Up 1.7%
Shares of Synopsys stock opened at $447.64 on Friday. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market cap of $83.15 billion, a PE ratio of 35.14, a price-to-earnings-growth ratio of 4.85 and a beta of 1.10. The company has a 50-day moving average of $525.72 and a two-hundred day moving average of $510.23.
Insider Activity at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the transaction, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the transaction, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on SNPS shares. Wall Street Zen downgraded shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Citigroup cut shares of Synopsys from a “neutral” rating to an “underperform” rating in a report on Wednesday, September 10th. Piper Sandler cut their price target on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Rosenblatt Securities reissued a “neutral” rating and set a $605.00 price target (down from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Finally, Stifel Nicolaus cut their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, Synopsys has a consensus rating of “Hold” and a consensus price target of $569.67.
Get Our Latest Stock Analysis on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- This AI Chip Giant Could Be the Market’s Next Big Winner
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- What Are the FAANG Stocks and Are They Good Investments?
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.